Descriptive Heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque vitae magna aliquam, vehicula eros eget, lacinia mauris. Nullam laoreet quis nisl id tempus. Proin aliquam, massa id commodo laoreet, dui urna porttitor sapien, a cursus dolor mauris ac velit. Vivamus malesuada velit in odio aliquam, id pulvinar enim dignissim. Nunc blandit, nulla et semper gravida, est tellus ullamcorper mi, ut convallis justo risus ac felis. Quisque pharetra maximus dui, id tristique tellus tincidunt et. Praesent dignissim vulputate lorem, vitae ullamcorper sapien varius non.

Ut faucibus sapien sem, et efficitur eros consectetur id. Ut nunc dui, feugiat et dictum eget, aliquam a tellus. Duis commodo justo eu blandit tincidunt. Nullam vitae nisl lectus. Sed dignissim iaculis efficitur. In turpis lorem, scelerisque ac dignissim at, luctus quis lorem. Nunc scelerisque non sapien quis vulputate. Fusce et finibus libero, ac tincidunt quam. Praesent elit massa, auctor nec magna at, dapibus ultrices odio. Fusce pretium vitae orci vitae consectetur.

Disparities in HIV Care: The Mounting Epidemic Plaguing African Americans

Register NowLive Webcast | Monday, April 26, 2021 | 6:30 - 8:00pm ET | This CME Outfitters Live and OnDemand will address racial and ethnic health care disparities among at-risk individuals, with expert faculty discussing best practices for actively engaging Black/African Americans at risk for HIV, developing treatment strategies for older adults with HIV, and initiating and switching patients to ART based on safety and efficacy profiles, to optimize health and treatment outcomes throughout their lives.

Creating Action Steps for Linking Underserved Populations with Hepatitis C Care

Register NowLive Webcast | Tuesday, April 20, 2021 | 12:00 - 1:30pm ET | In this CME Outfitters Live and OnDemand webcast, expert faculty will discuss the many barriers to treating HCV in the IDU population, including stigma and established negative perceptions about people who inject drugs (PWID), with special attention paid to applying CDC universal screening guidelines to improve diagnosis and linkage to treatment, expanding treatment for HCV in primary care settings, and addressing disparities in HCV treatment initiation in underserved communities.

Test Your Knowledge: An Interactive Session on Emerging Data and Expert Insights on Hepatitis B

Register NowLive Webcast | Wednesday, April 7, 2021 | 12:00 - 1:30pm ET | Chronic hepatitis B (HBV) imposes a significant disease burden, and identifying those at risk for HBV is imperative to implementing effective care. Test your knowledge during this interactive CME Outfitters Live and OnDemand webcast featuring augmented reality animations that will reinforce the fibrotic consequence of untreated HBV. Data presentation and translation will showcase the importance of implementing routine screening protocols, optimizing efficacy and safety profiles of current agents when initiating or switching treatment, and routinely monitoring patients with HBV for disease progression, hepatocellular carcinoma, and HBV reactivation.

Clinical Trials of Emerging Therapies for Retinal Degeneration Patients: Hope and Opportunities

Register NowLive Webcast | Monday, April 5, 2021 | 7:00 - 8:00pm ET | More than 40 clinical trials for emerging retinal degenerative disease therapies are underway. The studies provide hope for patients and the opportunity for them to participate in the research. Presented in partnership with the Foundation Fighting Blindness.

Live Q&A: Rethinking Routines in Multiple Sclerosis Management: What the Future Holds for DMTs and Cognitive Assessment Strategies

Register NowLive Webcast | Wednesday, March 31, 2021 | 12:00 - 12:30pm ET | This live question and answer session is your opportunity to ask questions based on the CME Outfitters virtual symposium where expert faculty focused on the prognostic factors that should be considered when developing treatment plans for patient with MS, as well as the latest clinical data on approved and emerging DMTs.

Live Q&A: Unlocking the Value of Biosimilar Therapies in IBD

Register NowLive Webcast | Thursday, March 11, 2021 This live question-and-answer session is your opportunity to ask questions based on the CME Outfitters virtual symposium, where expert faculty focused on identifying key terminology related to biosimilar products, assessing evidence regarding the efficacy and safety of biosimilars in IBD, and improving patient-provider communication patterns on the topic of biosimilars. To view the full activity ahead of this live Q&A, click here.

What You Need to Know to Share the Metastatic Urothelial Carcinoma (mUC) Decision-Making with Your Physician

Register Now

Maintenance Therapy in mUC: Integrating Current Treatment Options into Practice

Register NowThe first episode of this CMEOCast podcast series on practice-changing treatment advances in mUC focuses on examining current 1L treatment options, including maintenance therapy to optimize patient outcomes in mUC.

Treatment and Sequencing Strategies: Providing the Best Care for Patients with Metastatic Urothelial Carcinoma (mUC)

Register NowThis CMEOCast podcast features expert faculty evaluating efficacy data for 1L and 2L sequencing strategies in patients with mUC highighting immune checkpoint inhibitors and other novel agents, as well as provide strategies for managing adverse events during treatment.

Informed Decisions: Sharing Safety and Efficacy Data with Patients with Metastatic Urothelial Carcinoma (mUC)

Register NowThe final episode of this CMEOCast podcast series on providing the best care for patients with mUC focuses on helping clinicians stay abreast of the evolving evidence for maintenance immunotherapy regimens, providing patients with education that will empower them to be stakeholders in their care, and considering patient perspectives and preferences as a part of shared decision-making, in order to choose the optimal evidence-based course of treatment.

Resources

Shared Decision Making

Dr. Mark Ballow talks about strategies for patients and their caregivers to improve communication with their doctors and healthcare teams.

Whiteboard Animation: Primary Immunodeficiency Disorders

  PID Whiteboard:  An animated guide for patients and caregivers on what PIs are, and what to expect from clinical visits during the diagnostic phase and treatment planning.

Animated Look at Prior Authorization in AMD

Download Animated Look at Prior Authorization in AMD

An Animated Look at Acute and Chronic Pain Pathways

Download the Animation Guide here (PDF)

Download Animated Look at Acute and Chronic Pain Pathways Video
Resource Links

Brief Adherence Rating Scale (BARS)

Medication Adherence Rating Scale (MARS) The total score ranges from 0-10 with a higher score indicating better adherence

Brief Psychiatric Rating Scale (BPRS) Comprehensive 24-item symptom scale

Hamilton Depression Rating Scale (HAM-D) The Hamilton Depression Rating Scale (HAM-D) has proven useful for many years as a way of determining a patient’s level of depression before, during, and after treatment.

Geriatric Depression Scale Short Form (GDS-SF) 15-item screening tool used to identify depression in older adults

Edinburgh Postnatal Depression Scale (EPDS) Proven to be an effective screening tool to identify patients at risk for “perinatal” depression. Mother asked to check the response that comes closest to how she has been feeling in the previous 7 days.

Patient Health Questionnaire (PHQ-2) Use the Patient Health Questionnaire (PHQ-2) to screen for depression.

Beck Depression Inventory-II (BDI-II) The Beck Depression Inventory-II (BDI-II): 1996 revision of the BDI 21-item self-report multiple-choice inventory ~ 10 minutes to complete. Widely used indicator of the severity of depression.

Bipolar Spectrum Diagnostic Scale (BSDS) The Bipolar Spectrum Diagnostic Scale (BSDS) is a descriptive story that captures subtle features of bipolar illness.

Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR-16) Quick Inventory of Depressive Symptomatology (Self-Report) (QIDS-SR-16) has proven useful for many years as a way of determining a patient’s level of depression before, during, and after treatment.